Biological Evaluation of pH-Responsive Polymer-Caged Nanobins for Breast Cancer Therapy

Sang-Min Lee; Richard W. Ahn; Feng Chen; Angela J. Fought; Thomas V. O’Halloran; Vincent L. Cryns; SonBinh T. Nguyen

doi:10.1021/nn100560p

journal article Aug 25, 2010

Biological Evaluation of pH-Responsive Polymer-Caged Nanobins for Breast Cancer Therapy

Sang-Min Lee

Richard W. Ahn Feng Chen

Angela J. Fought Thomas V. O’Halloran Vincent L. Cryns

SonBinh T. Nguyen

ACS Nano Vol. 4 No. 9 pp. 4971-4978 · American Chemical Society (ACS)

View at Publisher Save 10.1021/nn100560p

Topics

No keywords indexed for this article. Browse by subject →

References

40

[1]

Allen T. M. Science (2004) 10.1126/science.1095833

[2]

Nanocarriers as an emerging platform for cancer therapy

Dan Peer, Jeffrey M. Karp, Seungpyo Hong et al.

Nature Nanotechnology 2007 10.1038/nnano.2007.387

[3]

Davis M. E. Nat. Rev. Drug Discovery (2008) 10.1038/nrd2614

[4]

Drummond D. C. Pharmacol. Rev. (1999) 10.1016/s0031-6997(24)01426-1

[5]

Waterhouse D. N. Drug Saf. (2001) 10.2165/00002018-200124120-00004

[6]

Gabizon A. Cancer Res. (1994)

[7]

Maeda H. J. Controlled Release (2000) 10.1016/s0168-3659(99)00248-5

[8]

Bandak S. Anti-Cancer Drugs (1999) 10.1097/00001813-199911000-00007

[9]

Laginha K. M. Clin. Cancer Res. (2005) 10.1158/1078-0432.ccr-05-0343

[10]

Rui Y. J. Am. Chem. Soc. (1998) 10.1021/ja9742949

[11]

pH-sensitive liposomes: acid-induced liposome fusion.

J Connor, M B Yatvin, L Huang

Proceedings of the National Academy of Sciences 1984 10.1073/pnas.81.6.1715

[12]

Gerasimov O. V. Adv. Drug Delivery Rev. (1999) 10.1016/s0169-409x(99)00035-6

[13]

Zalipsky S. Bioconjugate Chem. (1999) 10.1021/bc990031n

[14]

Bergstrand N. Biophys. Chem. (2003) 10.1016/s0301-4622(03)00011-5

[15]

Lee S.-M. J. Am. Chem. Soc. (2007) 10.1021/ja070748i

[16]

Lee S.-M. J. Am. Chem. Soc. (2009) 10.1021/ja9017336

[17]

Tannock I. F. Cancer Res. (1989)

[18]

Vaupel P. Cancer Res. (1989)

[19]

Casey J. R. Nat. Rev. Mol. Cell Biol (2010) 10.1038/nrm2820

[20]

Haran G. Biochim. Biophys. Acta (1993) 10.1016/0005-2736(93)90105-9

[21]

Ma Q. J. Am. Chem. Soc. (2001) 10.1021/ja0156542

[22]

Li S.-D. Mol. Pharmaceutics (2008) 10.1021/mp800049w

[23]

Vonarbourg A. Biomaterials (2006) 10.1016/j.biomaterials.2006.03.039

[24]

Sun G. Biomacromolecules (2008) 10.1021/bm800246x

[25]

Chong C. S. Biochim. Biophys. Acta (1976) 10.1016/0005-2736(76)90192-9

[26]

Schurtenberger P. Biochim. Biophys. Acta (1984) 10.1016/0005-2736(84)90396-1

[27]

Silvius J. R. Biochemistry (1993) 10.1021/bi00211a045

[28]

Barltrop J. A. Bioorg. Med. Chem. Lett. (1991) 10.1016/s0960-894x(01)81162-8

[29]

Chen H. J. Am. Chem. Soc. (2006) 10.1021/ja064864h

[30]

Moyano J. V. J. Clin. Invest. (2006) 10.1172/jci25888

[31]

Neve R. M. Cancer Cell (2006) 10.1016/j.ccr.2006.10.008

[32]

Cleator S. Lancet Oncol. (2007) 10.1016/s1470-2045(07)70074-8

[33]

Yehiely F. Trends Mol. Med. (2006) 10.1016/j.molmed.2006.09.004

[34]

Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein

Nathan C Shaner, Robert E Campbell, Paul A Steinbach et al.

Nature Biotechnology 2004 10.1038/nbt1037

[35]

Evolution of new nonantibody proteins via iterative somatic hypermutation

Lei Wang, W. Coyt Jackson, Paul A. Steinbach et al.

Proceedings of the National Academy of Sciences 2004 10.1073/pnas.0407752101

[36]

Hoffman R. M. Nat. Rev. Cancer (2005) 10.1038/nrc1717

[37]

All animal experiments were performed in accordance with protocols approved by the Northwestern University Animal Care and Use Committee.

[38]

Littell R. C. J. Anim. Sci. (1998) 10.2527/1998.7641216x

[39]

Chen H. Angew. Chem., Int. Ed. (2009) 10.1002/anie.200903655

[40]

Chaires J. B. Biochemistry (1982) 10.1021/bi00260a004

Cited By

75

Targeting Engineered Nanoparticles for Breast Cancer Therapy

Kumar Ganesan, Yan Wang · 2021

Pharmaceutics

Nanohybrid carriers: the yin–yang equilibrium between natural and synthetic in biomedicine

Faezeh Ghorbanizamani, Hichem Moulahoum · 2020

Biomaterials Science

How the Incorporation of Pluronic Block Copolymers Modulates the Response of Lipid Membranes to Mechanical Stress

Afroditi Maria Zaki, Paola Carbone · 2017

Langmuir

Metrics

75

Citations

40

References

Details

Published: Aug 25, 2010
Vol/Issue: 4(9)
Pages: 4971-4978

Authors

S

Sang-Min Lee

Department of Chemistry; Center of Cancer Nanotechnology Excellence; Robert H. Lurie Comprehensive Cancer Center

R

Richard W. Ahn

Department of Chemistry; Center of Cancer Nanotechnology Excellence; Robert H. Lurie Comprehensive Cancer Center

F

Feng Chen

Center of Cancer Nanotechnology Excellence; Cell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology; Robert H. Lurie Comprehensive Cancer Center

A

Angela J. Fought

Department of Preventive Medicine, Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center

T

Thomas V. O’Halloran

Department of Chemistry; Department of Biochemistry, Molecular Biology, and Cell Biology; Center of Cancer Nanotechnology Excellence; Robert H. Lurie Comprehensive Cancer Center

V

Vincent L. Cryns

Center of Cancer Nanotechnology Excellence; Cell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology; Robert H. Lurie Comprehensive Cancer Center

S

SonBinh T. Nguyen

Department of Chemistry; Center of Cancer Nanotechnology Excellence; Robert H. Lurie Comprehensive Cancer Center

Cite This Article

Sang-Min Lee, Richard W. Ahn, Feng Chen, et al. (2010). Biological Evaluation of pH-Responsive Polymer-Caged Nanobins for Breast Cancer Therapy. ACS Nano, 4(9), 4971-4978. https://doi.org/10.1021/nn100560p

Biological Evaluation of pH-Responsive Polymer-Caged Nanobins for Breast Cancer Therapy

You May Also Like